Topical application of mitomycin C before versus after myringotomy: an experimental study

Area of Science:

• Otolaryngology
• Ophthalmology
• Surgical Research

Background:

• Nonlaser myringotomy is a common otologic procedure.
• Optimizing tympanic membrane healing after myringotomy is crucial for surgical outcomes.
• Mitomycin C (MMC) is an antifibrotic agent with potential applications in otologic surgery.

Purpose of the Study:

• To compare the effects of topical mitomycin C (MMC) applied before versus after nonlaser myringotomy on tympanic membrane healing in a rat model.
• To evaluate the impact of MMC timing on the patency duration of myringotomies.

Main Methods:

• Bilateral nonlaser myringotomies were performed in 12 rats.
• MMC was applied either pre-myringotomy (left ear) or post-myringotomy (right ear).
• Tympanic membrane patency was observed for 8 weeks.

Main Results:

• Myringotomies with post-perforation MMC application closed completely by day 35.
• 42% of myringotomies with pre-perforation MMC application remained patent at 8 weeks.
• One case in the pre-application group showed perforation enlargement and malleus destruction.

Conclusions:

• Topical MMC application to the intact tympanic membrane before nonlaser myringotomy prolongs perforation patency in rats.
• The timing of MMC application significantly influences tympanic membrane healing after myringotomy.
• Potential side effects of pre-application MMC warrant careful consideration.